Clinical Trial Update: Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 827 [Phase 1]

View source ↗

Summary

Phase 1 single-dose study assessing safety, tolerability, pharmacokinetics, and pharmacodynamics of AMG 827 in psoriasis completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• AMG 827

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Psoriasis | Phase 1 | Status: COMPLETED | Results posted: 2019-01-16